European NGS Services Market by Technology (SBS, SBL, SMRT, Pyrosequencing), Application (Exome Sequencing, CHIP-Seq), End User (Pharmaceutical Companies, Hospital), Disease [Oncology (Prostate, Lung, & Breast Cancer), Rare Diseases) - Forecast to 2020
The NGS services market in Europe is expected to reach USD 1,152 Million by 2020 from USD 444 Million in 2015, at a CAGR of 21% from 2015 to 2020. Factors such as rising preference of NGS over other platforms; rapid and cost-efficient sequencing; rising prevalence of inherited diseases; application of genomics in drug discovery; growing prevalence of cancer and other malignant diseases; and partnerships among companies, R&D centers, and universities are expected to drive market growth. However, high dependence on grants for R&D, lack of analytics, and stringent reimbursement policies are likely to restrict the growth of this market to a certain extent.
On the basis of technology, the European NGS services market is segmented into sequencing by synthesis (SBS), ion semiconductor, sequencing by ligation (SBL), pyro-sequencing, and SMRT. SBS is currently the largest market and is also expected to be the fastest-growing technology segments. This can be attributed to the fact that SBS provides the highest reads per run and also offers high sequencing yields as compared to other technology segments in this market.
The U.K. is expected to dominate the European NGS services market in 2015 and is also expected to grow at the highest CAGR. The U.K.’s prominence in this market can be attributed to two major factors—presence of numerous small and medium-sized service providers and government support in the form of funding.
Prominent players in the European NGS services market include Beijing Genomics Institute (BGI) (China), Macrogen (South Korea), Eurofins Genomics (Germany), Illumina (U.S.), DNA Vision (Belgium), CeGaT GmbH (Germany), Febit (U.S.), Genomnia (Italy), Microsynth (Switzerland), and Source Bioscience (U.K.).
Want to explore hidden markets that can drive new revenue in European NGS Services Market?
This report categorizes the European NGS services market into the following segments and subsegments:
European NGS Services Market, by Technology
- Sequencing by Synthesis (SBS)
- Ion Semiconductor
- Sequencing by Ligation (SBL)
- Pyro-sequencing
- SMRT
European NGS Services Market, by Application (I)
- Whole-genome Sequencing
- Exome Sequencing
- Targeted Sequencing/Gene Panels
- De Novo Sequencing
- RNA-seq
- ChiP-seq
- Methyl-seq
European NGS Services Market, by Application (II)
- Research Applications
- Clinical Applications
European NGS Services Market, by Disease Type
- Oncology
- Lung Cancer
- Breast Cancer
- Prostate Cancer
- Colorectal Cancer
- Others
- Inherited Rare Diseases
- Prenatal/Neonatal Disorder
- Other Diseases
European NGS Services Market, by End User
- Research Centers and Academic & Government Institutes
- Hospitals and Clinics
- Pharmaceutical and Biotechnology Companies
- Other End Users
European NGS Services Market, by Country
- U.K.
- Germany
- France
- Italy
- Spain
- Netherlands
- Rest of Europe (RoE)
European NGS Services Market Stakeholders:
- NGS Equipment Manufacturers, Vendors, and Distributors
- NGS Sequencing Services Companies
- NGS Bioinformatics/Data Analysis Companies
- Research Institutes and Government Organizations
- Venture Capitalists and Other Government Funding Organizations
- Research and Consulting Firms
- Healthcare Institutions (Hospitals, Medical Schools, and Outpatient Clinics)
- Pharmaceutical and Biotechnology Companies
- Contract Manufacturing Organizations (CMOs)
- Contract Research Organizations (CROs)
The European NGS services market is primarily driven by factors such as faster and cost-efficient sequencing; rising preference of NGS over other platforms; rising prevalence of inherited diseases; application of genomics in drug discovery; growing prevalence of cancer and other malignant diseases; and partnerships among companies, R&D centers, and universities. On the other hand, factors such as lack of analytics, high dependence on grants for R&D, and stringent reimbursement policies are likely to restrict the growth of this market to a certain extent.
The European NGS services market is segmented on the basis of technology, application, end user, disease type, and country.
On the basis of technology, the European NGS services market is segmented into sequencing by synthesis (SBS), ion semiconductor, sequencing by ligation (SBL), pyro-sequencing, and SMRT. On the basis of application (I), the market is segmented into whole-genome sequencing, exome sequencing, targeted sequencing/gene panels, de novo sequencing, RNA-seq, ChiP-seq, and methyl-seq. On the basis of application (II), the market is segmented into research and clinical applications. On the basis of disease type, the market is segmented into oncology, inherited rare diseases, prenatal/neonatal disorder, and other diseases. The NGS oncology services market is further subsegmented into lung cancer, breast cancer, prostate cancer, colorectal cancer, and others. On the basis of end users, the market is segmented into research centers and academic & government institutes, hospitals and clinics, pharmaceutical and biotechnology companies, and other end users.
Regionally, the European NGS services market is segmented into the U.K., Germany, France, Italy, Spain, Netherlands, and Rest of Europe (RoE). Increasing healthcare expenditure and growth in NGS technologies are the major growth drivers in most of the regional segments.
The prominent players in the European NGS services market include Beijing Genomics Institute (BGI) (China), Macrogen (South Korea), Eurofins Genomics (Germany), Illumina (U.S.), DNA Vision (Belgium), CeGaT GmbH (Germany), Febit (U.S.), Genomnia (Italy), Microsynth (Switzerland), and Source Bioscience (U.K.).
Exclusive indicates content/data unique to MarketsandMarkets and not available with any competitors.
Table of Contents
1 Introduction
1.1 Objectives
1.2 Market Definitions
1.3 Market Scope
2 Research Methodology
3 Executive Summary
4 Market Overview
4.1 Introduction
4.2 Evolution
4.3 Market Segmentation
4.4 Market Dynamics
4.4.1 Drivers
4.4.2 Restraints
4.4.3 Opportunities
4.4.4 Challenges
5 Industry Insights
5.1 Pricing Analysis
5.2 Investor Analysis
5.3 Pestel Analysis
6 Regulation and Certification Landscape
7 Customer Perception Analysis
8 Benchmark Parameters and Futuristic Trends
9 European NGS Services Market, By Technology
9.1 SBS
9.2 ION Semiconductor
9.3 SBL
9.4 Pyro-Sequencing
9.5 Smrt
10 European NGS Services Market, By Application
10.1 Application (I)
10.1.1 Research Applications
10.1.2 Clinical Applications
10.2 Application (II)
10.2.1 Rna-Sequencing
10.2.2 Targeted Sequencing
10.2.3 Exome Sequencing
10.2.4 Whole Genome Sequencing
10.2.5 Chip-Sequencing
10.2.6 Methyl-Sequencing
10.2.7 De Novo Sequencing
10.2.8 Others
11 European NGS Services Market, By Disease Type
11.1 Overview
11.2 Oncology
11.2.1 Lung Cancer
11.2.2 Breast Cancer
11.2.3 Prostate Cancer
11.2.4 Colorectal Cancer
11.2.5 Others
11.3 Rare Diseases
11.4 Prenatal/Neonatal Disorders
11.5 Others
12 European NGS Services Market, By End User
12.1 Research Centers, Academic & Government Institutes
12.2 Hospitals & Clinics
12.3 Pharmaceutical & Biotechnology Companies
12.4 Others
13 European NGS Services Market, By Geography
13.1 Introduction
13.2 U.K.
13.3 Germany
13.4 France
13.5 Italy
13.6 Spain
13.7 Netherlands
13.8 Rest of the Europe (RoE)
14 Competitive Landscape
14.1 New Product Launches
14.2 Government Funding
14.3 Market Share Analysis
15 Company Profiles
15.1 Beijing Genomics Institute (BGI)
15.2 Cegat (Centre for Genomics and Transcriptomics) GmbH
15.3 DNA Vision SA
15.4 Eurofins Genomics Inc.
15.5 Febit / Comprehensive Biomarker Center GmbH (CBC)
15.6 Genomnia Srl
15.7 Illumina Inc.
15.8 Macrogen Inc.
15.9 Microsynth AG
15.10 Seqomics
15.11 Source Bio Science
16 Appendix
16.1 Certified NGS Service Providers in Europe
16.2 Major End Users of NGS Services
16.3 Related Reports
List of Tables (67 Tables)
Table 1 European NGS Services Market Size, By Technology, 2013-2020 (USD Million)
Table 2 SBS Technology Based Services Market Size, By Country, 2013-2020 (USD Million)
Table 3 ION Semiconductor Technology Based Services Market Size, By Country, 2013-2020 (USD Million)
Table 4 SBL Technology-Based Services Market Size, By Country, 2013-2020 (USD Million)
Table 5 Pyrosequencing Technology Based Services Market Size, By Country, 2013-2020 (USD Million)
Table 6 Smart Technology Based Services Market Size, By Country, 2013-2020 (USD Million)
Table 7 European NGS Services Market Size, By Application (I), 2013-2020 (USD Million)
Table 8 NGS Services Market Size for Research Applications, By Country, 2013-2020 (USD Million)
Table 9 NGS Services Market Size for Clinical Applications, By Country, 2013-2020 (USD Million)
Table 10 European NGS Services Market Size, By Application (II), 2013-2020 (USD Million)
Table 11 RNA-Seq Services Market Size, By Country, 2013-2020 (USD Million)
Table 12 Targeted Sequencing/Gene Panels Services Market Size, By Country, 2013-2020 (USD Million)
Table 13 Exome Sequencing Services Market Size, By Country, 2013-2020 (USD Million)
Table 14 Whole Genome Sequencing Services Market Size, By Country, 2013-2020 (USD Million)
Table 15 Chip-Seq Services Market Size, By Country, 2013-2020 (USD Million)
Table 16 Methyl-Seq Services Market Size, By Country, 2013-2020 (USD Million)
Table 17 De Novo Sequencing Services Market Size, By Country, 2013-2020 (USD Million)
Table 18 Other Sequencing Services Market Size, By Country, 2013-2020 (USD Million)
Table 19 NGS Services Market Size, By Disease Type, 2013–2020 (USD Million)
Table 20 European NGS Oncology Services Market, By Cancer Type, 2013-2020 (USD Million)
Table 21 NGS Services Market Size for Lung Cancer, By Country, 2013-2020 (USD Million)
Table 22 NGS Services Market Size for Breast Cancer, By Country, 2013-2020 (USD Million)
Table 23 NGS Services Market Size for Prostate Cancer, By Country, 2013-2020 (USD Million)
Table 24 NGS Services Market Size for Colorectal Cancer, By Country, 2013-2020 (USD Million)
Table 25 NGS Services Market Size for Other Oncology Diseases, By Country, 2013-2020 (USD Million)
Table 26 European NGS Services Market Size, By End-User, 2013-2020 (USD Million)
Table 27 NGS Services Market Size for Research Centers, Academic & Government Institutes, By Country, 2013-2020 (USD Million)
Table 28 NGS Services Market Size for Hospitals & Clinics, By Country, 2013-2020 (USD Million)
Table 29 NGS Services Market Size for Pharmaceutical & Biotechnology Companies, By Country, 2013-2020 (USD Million)
Table 30 NGS Services Market Size for Other End Users, By Country, 2013-2020 (USD Million)
Table 31 European NGS Services Market Size, By Country, 2013-2020 (USD Million)
Table 32 European Oncology NGS Services Market Size, By Country, 2013-2020 (USD Million)
Table 33 U.K.: NGS Services Market Size, By Technology, 2013-2020 (USD Million)
Table 34 U.K.: NGS Services Market Size, By Applications (I), 2013-2020 (USD Million)
Table 35 U.K.: NGS Services Market Size, By End-User, 2013-2020 (USD Million)
Table 36 U.K.: NGS Services Market Size, By Applications (II), 2013-2020 (USD Million)
Table 37 U.K.: NGS Oncology Services Market Size, By Type, 2013-2020 (USD Million)
Table 38 Germany: NGS Services Market Size, By Technology, 2013-2020 (USD Million)
Table 39 Germany: NGS Services Market Size, By Applications (I), 2013-2020 (USD Million)
Table 40 Germany: NGS Services Market Size, By End-User, 2013-2020 (USD Million)
Table 41 Germany: NGS Services Market Size, By Applications (II), 2013-2020 (USD Million)
Table 42 Germany: Oncology NGS Services Market Size, By Type, 2013-2020 (USD Million)
Table 43 France: NGS Services Market Size, By Technology, 2013-2020 (USD Million)
Table 44 France: NGS Services Market Size, By Applications (I), 2013-2020 (USD Million)
Table 45 France: NGS Services Market Size, By End-User, 2013-2020 (USD Million)
Table 46 France: NGS Services Market Size, By Applications (II), 2013-2020 (USD Million)
Table 47 France: Oncology NGS Services Market Size, By Type, 2013-2020 (USD Million)
Table 48 Italy: NGS Services Market Size, By Technology, 2013-2020 (USD Million)
Table 49 Italy: NGS Services Market Size, By Applications (I), 2013-2020 (USD Million)
Table 50 Italy: NGS Services Market Size, By End-User, 2013-2020 (USD Million)
Table 51 Italy: NGS Services Market Size, By Applications, (II) 2013-2020 (USD Million)
Table 52 Italy: Oncology NGS Services Market Size, By Type, 2013-2020 (USD Million)
Table 53 Spain: NGS Services Market, By Technology Size, 2013-2020 (USD Million)
Table 54 Spain: NGS Services Market Size, By Applications (I), 2013-2020 (USD Million)
Table 55 Spain: NGS Services Market Size, By End-User, 2013-2020 (USD Million)
Table 56 Spain: NGS Services Market Size, By Applications (II) 2013-2020 (USD Million)
Table 57 Spain: Oncology NGS Services Market Size, By Type, 2013-2020 (USD Million)
Table 58 Netherlands: NGS Services Market Size, By Technology, 2013-2020 (USD Million)
Table 59 Netherlands: NGS Services Market Size, By Applications (I), 2013-2020 (USD Million)
Table 60 Netherlands: NGS Services Market Size, By End-User, 2013-2020 (USD Million)
Table 61 Netherlands: NGS Services Market Size, By Applications (II), 2013-2020 (USD Million)
Table 62 Netherlands: Oncology NGS Services Market Size, By Type, 2013-2020 (USD Million)
Table 63 RoE: NGS Services Market, By Technology Size, 2013-2020 (USD Million)
Table 64 RoE: NGS Services Market Size, By Applications(I), 2013-2020 (USD Million)
Table 65 RoE: NGS Services Market Size, By End-User , 2013-2020 (USD Million)
Table 66 RoE: NGS Services Market Size, By Applications (II), 2013-2020 (USD Million)
Table 67 RoE: Oncology NGS Services Market Size, By Type, 2013-2020 (USD Million)
List of Figures (12 Figures)
Figure 1 Market Size, 2015-2020 (USD Million)
Figure 2 Customer Segmentation, 2015
Figure 3 Country-Wise Market Share, 2015
Figure 4 Market Size, 2014–2020 (USD Million)
Figure 5 Pricing Analysis
Figure 6 European NGS Services Market Size, By Technology, 2015 & 2020 (USD Million)
Figure 7 Market Size, By Technology, 2011–2020 (USD Million)
Figure 8 Market Size, By Applications (I), 2015 & 2020 (USD Million)
Figure 9 Market Size, By Application (II), 2015 & 2020 (USD Million)
Figure 10 Market Size, By Disease Type, 2015 & 2020 (USD Million)
Figure 11 Market Size, By End User, 2011–2020 (USD Million)
Figure 12 Market Share (2014)
Generating Response ...
Growth opportunities and latent adjacency in European NGS Services Market